In the minds of many people, math lives in the classroom—on blackboards, in textbooks, and in tests. New research from Amber Simpson, associate professor in the Department of Teaching, Learning, and ...
A sweeping investigation has revealed widespread fraud in mathematics publishing, where commercial metrics and rankings have incentivized the mass production of meaningless or flawed papers. The study ...
When in high school, one is usually caught up with the usual challenges of teenage life, including getting good grades, navigating through crushes, and figuring out who one’s true friends are. But for ...
CNET editor Gael Fashingbauer Cooper, a journalist and pop-culture junkie, is co-author of "Whatever Happened to Pudding Pops? The Lost Toys, Tastes and Trends of the '70s and '80s," as well as "The ...
OpenAI Group PBC today launched a new large language model that is significantly better than its predecessors at solving math problems and writing code. GPT-5.5 is rolling out a week after rival ...
Katelyn is a reporter with CNET covering artificial intelligence, including chatbots, image and video generators. Her work explores how new AI technology is infiltrating our lives, shaping the content ...
Add Popular Science (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results.
A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. GLP-1s are ...
Investigator-assessed PFS improved with atirmociclib plus fulvestrant versus fulvestrant alone or everolimus/exemestane, achieving HR 0.60 and meeting the primary endpoint with clinically meaningful ...
GPT just keeps getting better at mathematics, increasingly solving the trickiest of problems. In January, AI testing company Epoch AI found that a previous version of the AI model, GPT-5.2 Pro had ...
GLP‑1 drugs may fight addiction across every major substance, according to a study of 600,000 people
A patient of mine, a veteran who had tried to quit smoking for over a decade, told me that after he started a GLP-1 drug for his diabetes, he lost interest in cigarettes. He didn’t use a patch. He ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results